Back to Companies
Vivos Therapeutics, Inc.
VVOSNasdaqCIK: 0001716166
Vivos Therapeutics, Inc. (VVOS) shows 8 recent insider filings from 7 insiders, with all of them on the buy side. With $1.8M in purchases and $0 in sales, the recent tape is heavily weighted toward buying (a net purchase of $1.8M). Skaff Michael C is the most active by dollar volume, and the single largest transaction was $5.7M by Skaff Michael C. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$8.5M
Purchases
$1.8M
Sales
$0
Unique Insiders
7
Recent Insider Trades
8 loaded
| Sep 18 | VVOS Vivos Therapeutics, Inc. | JOHNSON GREGG C | Director | Award | $2.2K |
| Sep 18 | VVOS Vivos Therapeutics, Inc. | SOKOLOW LEONARD J | Director | Award | $2.2K |
| Aug 26 | VVOS Vivos Therapeutics, Inc. | Amman Bradford K. | Principal Accounting Officer | Grant | $102.5K |
| Jul 15 | VVOS Vivos Therapeutics, Inc. | Skaff Michael C | Insider | Other | $2.5M |
| Jul 15 | VVOS Vivos Therapeutics, Inc. | V-Co Investors 4 LLC | Insider | Other | $0 |
| Sep 18 | VVOS Vivos Therapeutics, Inc. | Huntsman Ronald Kirk | Chief Executive Officer, Director | Other | $89.2K |
| Apr 2 | VVOS Vivos Therapeutics, Inc. | Skaff Michael C | Insider | Buy | $1.8M |
| Apr 10 | VVOS Vivos Therapeutics, Inc. | V-Co Investors 3 LLC | Insider | Other | $0 |
8 filings